PETCO HEALTH CL.A DL-,001

Petco reported Q2 2026 revenue of $1.5 billion and comparable-store growth of 0.6%, its second consecutive positive quarter. Adjusted EBITDA was $122 million and gross margin rose to 39.7%, prompting a sharp after-hours stock gain. Management reaffirmed the full-year outlook (revenue 0–1.5%, adjusted EBITDA $415–430 million) and emphasized progress in stores, digital, services and veterinary. Petco reported strong growth in the cat segment, weakness in dogs, plans 15–20 net store closures and continues to prioritize debt reduction. » More on de.investing.com

Chief people officer Holly May sold 200,000 Class A common shares of Petco Health and Wellness Company on July 9 at a weighted average price of $2.54 per share (transaction range $2.51–$2.60). The sale amounted to roughly $508,000; after the transaction May beneficially owns 1,327,867 shares, including 1,326,218 RSUs. The stock came under about 1.6% pressure in premarket trading after the insider sale became known. » More on de.investing.com

Petco reported FQ1 net sales of $1.5 billion and a return to positive comparable sales growth of 0.7%, with gross profit rising to $574.4 million while reporting a net loss of $15.1 million. The company cut total debt to $1.482 billion and ended the quarter with $166.8 million in cash. Management reaffirmed its full-year 2026 outlook, guided for Q2 and said it will focus on strengthening retail fundamentals and improving profitability. Hedge funds name Petco among attractive value penny stocks. » More on finance.yahoo.com